EyeGate Pharma - da brennt die Bude!

Hier die News dazu:
Shares of EyeGate Pharmaceuticals Inc. EYEG, +47.39% rallied 95% in premarket trading on the news that the company's experimental eye-drop bandage performed better than the standard of care, which is a bandage contact lens, in patients in need of corneal wound repair. EyeGate plans to submit a de novo application to the Food and Drug Administration in the first six months of 2020. "If approved, [it] will be the first product indicated to repair corneal defects, as well as the first prescription hyaluronic acid eye drop in the U.S.," EyeGate CEO Stephen From said in a release. The company said it expects to receive additional data next week. EyeGate stock has fallen 31% year-to-date. The S&P 500 SPX, +0.01% has jumped 24%.

https://www.marketwatch.com/story/...-2019-11-22?mod=newsviewer_click

https://old.nasdaq.com/de/symbol/eyeg/real-time

About

http://www.eyegatepharma.com/
 

https://old.nasdaq.com/de/symbol/eyeg/real-time  

Nächster Move...?!





 

 

 

https://seekingalpha.com/news/...eed_news_all&utm_medium=referral

https://old.nasdaq.com/de/symbol/eyeg/real-time  

https://www.globenewswire.com/news-release/2020/...noptes-Pharma.html  

8 Mio. $ Privatplatzierung  

https://www.benzinga.com/general/biotech/21/07/...-after-hours-monday  

Denke das könnte schnell wieder abverkauft werden.  

Richtig gedacht.  

MK 17 Mio. $  

10,75 Mio. $ Offering

• 4,7 Mio. neue Aktien zu 2,30$
  

https://www.globenewswire.com/news-release/2021/...-Nasdaq-Rules.html